Characterization of a lactate metabolism-related signature for evaluation of immune features and prediction prognosis in glioma.

We explored the characteristics of LMGs in glioma and proposed an LMG-based signature. This prognostic model could predict the survival of patients with glioma and help clinical oncologists plan more individualized and effective therapeutic regimens.